LightPath Technologies Inc
LightPath Technologies Inc (LPTH) designs and manufactures precision optical components and assemblies — including glass and polymer lenses, infrared optics and customised assemblies — for customers in defence, industrial, medical and commercial markets. The company’s products support thermal imaging, night vision, laser systems and other sensor applications. As a small-cap specialist (market cap $370.76M) it can offer niche technology and agility, but also faces typical small-company volatility and execution risks. Investors may watch revenue mix, margin trends, order book visibility and contracts with defence and industrial customers, together with supply-chain stability and investments in manufacturing capacity. The stock is potentially of interest to those wanting exposure to photonics and sensing technology trends; however, values can rise and fall and past performance is no guarantee of future results. This information is general and educational only and not personalised investment advice — suitability depends on an investor’s objectives, time horizon and risk tolerance.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying LightPath Technologies’ stock with a target price of $4.25, indicating strong growth potential.
Financial Health
LightPath Technologies is making moderate revenue and cash flow, but profit margins are somewhat low.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring LPTH
Solar Eclipse Black Box
This carefully selected group of stocks represents breakthrough technologies developing in the shadows before their dramatic market emergence. Our professional analysts have identified companies pioneering quantum computing, gene editing, and other innovations with potential for explosive growth once they step into the spotlight.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Precision optics focus
Specialist products for thermal imaging and sensor systems can benefit from rising demand for electro‑optical capabilities, though revenue can be lumpy.
Diverse end markets
Sales span defence, medical and industrial customers, offering market diversification while remaining sensitive to defence budgets and industrial cycles.
Small‑cap considerations
The company’s size offers agility and niche expertise but also brings higher volatility and execution risk; consider this when assessing suitability.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
